Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Permissive underfeeding and intensive insulin therapy in critically ill patients: a randomized controlled trial.

Arabi YM, Tamim HM, Dhar GS, Al-Dawood A, Al-Sultan M, Sakkijha MH, Kahoul SH, Brits R.

Am J Clin Nutr. 2011 Mar;93(3):569-77. doi: 10.3945/ajcn.110.005074. Epub 2011 Jan 26.

2.

Permissive Underfeeding or Standard Enteral Feeding in Critically Ill Adults.

Arabi YM, Aldawood AS, Haddad SH, Al-Dorzi HM, Tamim HM, Jones G, Mehta S, McIntyre L, Solaiman O, Sakkijha MH, Sadat M, Afesh L; PermiT Trial Group.

N Engl J Med. 2015 Jun 18;372(25):2398-408. doi: 10.1056/NEJMoa1502826. Epub 2015 May 20. Erratum in: N Engl J Med. 2015 Sep 24;373(13):1281.

3.

Permissive underfeeding versus target enteral feeding in adult critically ill patients (PermiT Trial): a study protocol of a multicenter randomized controlled trial.

Arabi YM, Haddad SH, Aldawood AS, Al-Dorzi HM, Tamim HM, Sakkijha M, Jones G, McIntyre L, Mehta S, Solaiman O, Sadat M, Afesh L, Sami B.

Trials. 2012 Oct 12;13:191. doi: 10.1186/1745-6215-13-191.

4.

Comparison of a high-protein disease-specific enteral formula with a high-protein enteral formula in hyperglycemic critically ill patients.

Mesejo A, Acosta JA, Ortega C, Vila J, Fernández M, Ferreres J, Sanchis JC, López F.

Clin Nutr. 2003 Jun;22(3):295-305.

PMID:
12765670
5.

Calorie intake of enteral nutrition and clinical outcomes in acutely critically ill patients: a meta-analysis of randomized controlled trials.

Choi EY, Park DA, Park J.

JPEN J Parenter Enteral Nutr. 2015 Mar;39(3):291-300. doi: 10.1177/0148607114544322. Epub 2014 Jul 30.

PMID:
25078609
6.

[The influence of intensive insulin therapy on the mortality of critically ill patients in intensive care unit: a meta-analysis].

Li J, Li L, Ma B, Yang KH.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009 Jun;21(6):349-52. Chinese.

7.

Permissive Underfeeding or Standard Enteral Feeding in High- and Low-Nutritional-Risk Critically Ill Adults. Post Hoc Analysis of the PermiT Trial.

Arabi YM, Aldawood AS, Al-Dorzi HM, Tamim HM, Haddad SH, Jones G, McIntyre L, Solaiman O, Sakkijha MH, Sadat M, Mundekkadan S, Kumar A, Bagshaw SM, Mehta S; PermiT trial group.

Am J Respir Crit Care Med. 2017 Mar 1;195(5):652-662. doi: 10.1164/rccm.201605-1012OC.

PMID:
27589411
8.

A phase II randomised controlled trial of intensive insulin therapy in general intensive care patients.

Mitchell I, Knight E, Gissane J, Tamhane R, Kolli R, Leditschke IA, Bellomo R, Finfer S; Australian and New Zealand Intensive Care Society Clinical Trials Group.

Crit Care Resusc. 2006 Dec;8(4):289-93.

PMID:
17227263
9.

Efficacy and safety of intensive insulin therapy for critically ill neurologic patients: a meta-analysis.

Shan L, Hao PP, Chen YG.

J Trauma. 2011 Nov;71(5):1460-4. doi: 10.1097/TA.0b013e3182250515.

PMID:
22071938
10.

Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients.

Arabi YM, Dabbagh OC, Tamim HM, Al-Shimemeri AA, Memish ZA, Haddad SH, Syed SJ, Giridhar HR, Rishu AH, Al-Daker MO, Kahoul SH, Britts RJ, Sakkijha MH.

Crit Care Med. 2008 Dec;36(12):3190-7. doi: 10.1097/CCM.0b013e31818f21aa.

PMID:
18936702
11.

Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality.

Meyfroidt G, Keenan DM, Wang X, Wouters PJ, Veldhuis JD, Van den Berghe G.

Crit Care Med. 2010 Apr;38(4):1021-9. doi: 10.1097/CCM.0b013e3181cf710e.

PMID:
20124887
12.

Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data.

Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, Dhaliwal R, Henderson WR, Chittock DR, Finfer S, Talmor D.

CMAJ. 2009 Apr 14;180(8):821-7. doi: 10.1503/cmaj.090206. Epub 2009 Mar 24. Review.

13.

A literature review of intensive insulin therapy and mortality in critically ill patients.

Chen L.

Clin Nurse Spec. 2010 Mar-Apr;24(2):80-6. doi: 10.1097/NUR.0b013e3181cf55af. Review.

PMID:
20168143
15.

Dissemination of the Canadian clinical practice guidelines for nutrition support: results of a cluster randomized controlled trial.

Jain MK, Heyland D, Dhaliwal R, Day AG, Drover J, Keefe L, Gelula M.

Crit Care Med. 2006 Sep;34(9):2362-9.

PMID:
16850001
16.

Intensive insulin therapy and mortality in critically ill patients.

Treggiari MM, Karir V, Yanez ND, Weiss NS, Daniel S, Deem SA.

Crit Care. 2008;12(1):R29. doi: 10.1186/cc6807. Epub 2008 Feb 29.

17.

Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.

Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P.

Crit Care Med. 2003 Feb;31(2):359-66.

PMID:
12576937
18.

Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm.

Van den Berghe G, Wilmer A, Milants I, Wouters PJ, Bouckaert B, Bruyninckx F, Bouillon R, Schetz M.

Diabetes. 2006 Nov;55(11):3151-9.

19.

Early enteral administration of immunonutrition in critically ill children: results of a blinded randomized controlled clinical trial.

Briassoulis G, Filippou O, Hatzi E, Papassotiriou I, Hatzis T.

Nutrition. 2005 Jul-Aug;21(7-8):799-807.

PMID:
15975487
20.

Supplemental Content

Support Center